PYLOPASS®
A new approach in
H. pylori control
Pylopass® is a proprietary strain, Lactobacillus reuteri DSMZ 17648, which specifically binds and coaggregates with H.pylori to reduce the bacterial load.
- Reduction in H.pylori load in 2 weeks.
- Pylopass® does not alter the gut microbiota.
- Pylopass® does not contribute to the antibiotic resistance.
DYSPEPCYN™
A scientifically calibrated approach to restoring digestive harmony
DyspepCyn™ combines standardized botanical extracts of artichoke (Cynara scolymus L.) leaf, ginger (Zingiber officinale Rosc.) rhizome and lemon peel (Citrus limon (L.) Osbeck.), developed to target the physiological mechanisms underlying functional dyspepsia (FD), a condition affecting up to 20% of the population.
- Supports bile secretion, lipid digestion and gastric motility, helping to reduce postprandial fullness, bloating and epigastric discomfort.
- Clinically validated in a dose-finding crossover study in Functional Dyspepsia outpatients (Rome IV criteria).
- At the 1000 mg/day dose, 70% of patients reached a Global Overall Symptom score ≤2 and a mean 6.2-point reduction in the Leeds Dyspepsia Questionnaire (LDQ).
- All doses were well tolerated, with no gastrointestinal adverse events reported.
- Dosage: 250–1000 mg/day (clinically tested range).
Natural remedy to reduce or eliminate occasional constipation
Mallolax™️ is an osmotic laxative that works against intestinal dysmotility thanks to its antioxidant properties.
Malva Sylvestris, L. aerial part dry extract grown in North Africa
- ≥ 7,5 % Total polyphenols
- ≥ 5,0 % Polyphenols as malvidin
- ≥ 30,0 % Mucilage
- 500mg-1g once daily
- HAD Free: Regulation (EU) 2021/468 of 18 March 2021
A non animal water soluble ingredient for calorie control
- Fat trapping capability: 80% of daily intake.
- 2500 times more active than regular Chitosan.
- H2OSLIM® is 60% more effective than Chitosan+Succinic Acid.
- Low dosage: 400 mg before main meals.
- Non-animal polysaccharides 100% water soluble.
